References
- Piel FB, Tatem AJ, Huang Z, et al. Global migration and the changing distribution of sickle haemoglobin: a quantitative study of temporal trends between 1960 and 2000. Lancet Glob Health. 2014;2(2):e80–e89.
- Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001;79(8):704–712.
- Angastiniotis M, Vives Corrons JL, Soteriades ES, et al. The impact of migrations on the health services for rare diseases in Europe: the example of haemoglobin disorders. Sci World J. 2013;2013:727905.
- Osservatorio sull’immigrazione della provincia di Modena. Available from: www.provincia.modena.it/sociale.
- Venturelli D, Lodi M, Palazzi G, et al. Sickle cell disease in areas of immigration of high-risk populations: a low cost and reproducible method of screening in northern Italy. Blood Transfus. 2014;12(3):346–351.
- National guidelines for physiological pregnancy. Italian National Institute of Health. 2011 update (http://www.salute.gov.it/imgs/C_17_pubblicazioni_1436_allegato.pdf).
- New Legistalitve Decree of October 21 2005, no. 219. New transfusion discipline of transfusion and national production of blood products. Official Gazette of the Italian Republic; General Series no. 251 of October 27 2005 (http://www.camera.it/parlam/leggi/05219l.htm).
- Decree of the Minister of Health, March 3 2005, article 14, paragraph 3. Characteristics and methods for the donation of blood and blood components. Official Gazette of the Italian Republic; General Series no. 85 of April 13 2005 (http://www.gazzttaufficialle.it/atto/serie_generale/carcaDettaglioAtto/origina-rioatto.dataPubblicazioneGazzetta =205-0413&att9o.codiceRed-azionale =05A03442&elenco30giorni=false).
- Eastman JW, Wong R, Liao CL, et al. Automated HPLC screening of newborns for sickle cell anemia and other hemoglobinopathies. Clin Chem. 1996;42(5):704–710.
- Pass KA, Lane PA, Fernhoff PM, et al. US newborn screening system guidelines II: follow-up of children, diagnosis, management, and evaluation. Statement of the Council of Regional Networks for Genetic Services (CORN). J Pediatr. 2000;137(4 Suppl):S1–S46.
- Rolla R, Castagno M, Zaffaroni M, et al. Neonatal screening for sickle cell disease and other hemoglobinopathies in the changing Europe. Clin Lab. 2014;60(12):2089–2093.
- Ballardini E, Tarocco A, Marsella M, et al. Universal neonatal screening for sickle cell diasese and other haemoglobinopathies in Ferrara, Italy. Blood Transfus. 2013:11(2):245–249.
- Streetly A, Latinovic R, Henthorn J. Positive screening and carrier results for the England-wide universal newborn sickle cell screening programme by ethnicity and area for 2005-07. J Clin Pathol. 2010;63(7):626–629.
- Jans SM, van El CG, Houwaart ES, et al. A case study of haemoglobinopathy screening in the Netherlands: witnessing the past, lessons for the future. Ethn Health. 2012;17(3):217–239.
- Gulbis B, Cotton F, Ferster A, et al. Neonatal haemoglobinopathy screening in Belgium. J Clin Pathol. 2009;62(1):49–52.
- Cela de Julián E1, Dulín Iñiguez E, Guerrero Soler M, et al. Evaluation of systematic neonatal screening for sickle cell diseases in Madrid three years after its introduction. An Pediatr (Barc). 2007;66(4):382–386.
- Lobitz S, Frömmel C, Brose A. Incidence of sickle cell disease in an unselected cohort of neonates born in Berlin, Germany. Eur J Hum Genet. 2014;22(8):1051–1053.
- Bardakdjian-Michau J, Bahuau M, Hurtrel D, et al. Neonatal screening for sickle cell disease in France. J Clin Pathol. 2009;62(1):31–33.
- Quinn CT, Rogers ZR, McCavit TL, et al. Improved survival of children and adolescents with sickle cell disease. Blood. 2010;115(17):3447–3452.